Strategies to Enhance the Hep C Care Cascade Among People Who Inject Drugs
February 24, 2016, Mount Sinai – Beth Israel: 10 Union Square East
Strategies to Enhance the Hepatitis C Care Cascade Among People Who Inject Drugs
Jason Grebely, BSc, PhD, Kirby Institute, UNSW Australia – Jgrebely@kirby.unsw.edu.au
- Hep C Among People Who Inject Drugs
- Burden of Hep C infection among people who inject drugs
- Strategies to enhance Hep C testing, assessment, treatment uptake and treatment outcomes
- Hep C reinfection post-treatment
- Project Overview
- ETHOS (Enhancing Treatment of Hep C in the Opioid Substitution setting): Hep C assessment and treatment in the drug and alcohol setting (in partnership with New South Wales Health)
- LiveRLife: A healthy liver intervention based on social marketing promotion to enhance liver disease assessment in the drug and alcohol setting
- SToP-C: Hep C treatment as prevention project in prisons
NYC Best Practices in Hep C Care and Treatment for People Who Use Drugs
Alain Litwin, MD, Professor of Medicine and Psychiatry at Albert Einstein College of Medicine and Montefiore Medical Center – ALITWIN@montefiore.org
Sheila Reynoso, Project Coordinator Montefiore Medical Center sreynoso@montefiore.org
NYS Medicaid and Managed Care Plans
Current Hep C medication coverage criteria for people with current or past drug use.
- Hepatitis C clinical criteria for Fee For Service Medicaid were posted in the Oct 2014 Medicaid update. There was an update including the availability of Viekira Pak without restriction in the April 2015 Medicaid Update.
- NYS Medicaid Managed Care plans each have their own list of covered drugs (called a formulary).
- See HepCure Webinar Archives: www.hepcure.org > webinars
NYS DOH Presentation “Prior Authorization of Hepatitis C Medications in Medicaid Fee for Service (FFS) and Medicaid Managed Care” given by Monica Toohey M (HEALTH) monica.toohey@health.ny.gov
In Attendance:
- Alain Litwin Professor of Medicine Montefiore Medical Center alitwin@montefiore.org
- Amber Casey Deputy Director DOHMH acasey@health.nyc.gov
- Angel Hernandez Peer Navigator Montefiore Medical Center
- Ariel Caba Intake Specialist Harlem United acaba@harlemunited.org
- Asmara Tesfaye Rogoza Viral Hepatitis Coordinator DOHMH – Viral Hepatitis atesfayerogoza@health.nyc.gov
- Benjamin Eckhardt Infectious Diseases Fellow Weill Cornell Medical Center bje8@cornell.edu
- Bobby Kim Senior Therapeutic Specialist Gilead kim@gilead.com
- Bridget Hardy Account Manager Quality Specialty Pharmacy, bridget@qsprx.com
- Brigitte Buquez Program Development Hudson Pride Connections Center buquez@gmail.com
- Charles Lott Hepatitis C Peer Worker Housing Works nj5@gmail.com
- Cinthia Castro Patient Navigator Harlem United Ccastro@harlemunited.org
- Curtis Melton Virology Specialist Bristol Myers Squibb melton@bms.com
- Daniel Calder Outreach Coordinator DOHMH dcalder@health.nyc.gov
- Debra Farrun Pharmaceutical Rep Gilead farrun@gilead.com
- Diana Diaz-Munoz Program Intern DOHMH ddiazmunoz@health.nyc.gov
- Ella Culler Hep C Harm Reduction Trainer Housing Works culler@housingworks.org
- Elly Fatehi Director of Pharmacy Amida Care efatehi@amidacareny.org
- Evelyn Parrinello Info & Referral Specialist Community Health Action of Staten Island PARRINELLO@CHASINY.ORG
- Farah Riazi Patient Navigator Mount Sinai riazi@mountsinai.org
- Farmin Khiabani Virology Representative Merck khiabani@merck.com
- Frank Winter External Affairs Centers for Medicare & Medicaid Services winter@cms.hhs.gov
- Genesis Ciprian Patient Navigator Mount Sinai Hospital ciprian@mountsinai.org
- Gretchen George Ty Harm Reduction Coordinator Housing Works Ty@housingowrks.org
- Iraida Ramos Peer Navigator BOOM!Health iris1498@yahoo.com
- Ivana Portes Co-Directors Ann’s Corner of Harm Reduction iportes@sachr.org
- Jamin Aliseo Hepatitis C Peer Worker Housing Works jaliseo5170@gmail.com
- Jason Grebeley Researcher Kirby Institute jgrebely@kirby.unsw.edu.au
- Jennifer Grimsich Merck grimsich@merck.com
- Kathryn Villaverde Harm Reduction Counselor Housing Works villaverde@housingworks.org
- Kendra Pemberton Regional Director HCV Gilead pemberton@gilead.com
- Kenny Ng Pharmacy Intern Amida Care kng@amidacareny.org
- Korin Parrella Program Manager Mount Sinai Hep C Primary Care Program parrella@mountsinai.org
- Kyle Wanger Hep C Clinical educator Gilead wanger@gilead.com
- Leo Yanacio Acct Manager Quality Specialty Pharmacy leo@asprx.com
- Matt Scherer MD Columbia Presbyterian Medical Center mls2002@nyp.org
- Michael Brown Peer Navigator BOOM!Health haneef2676@gmail.com
- Miguel Calderon Harm Reduction Supervisor BOOM!Health mcalderon@boomhealth.org
- Miranda Moore MPH DOHMH – Viral Hepatitis mmoore3@health.nyc.gov
- Nasra Aidarus Program Planner DOHMH naidarus@health.nyc.gov
- Nathalia Gibbs Hep C patient Navigator Mount Sinai gibbs@mountsinai.org
- Nirah Johnson Director of Program Implementation & Capacity Building DOHMH – Viral Hepatitis njohnso2@health.nyc.gov
- Paul Bolter Health Education American Liver Foundation pbolter@liverfoundation.org
- Perminder Khosa Epidemiologist DOHMH – Viral Hepatitis pkhosa@health.nyc.gov
- Sheila Reynoso Project Coordinator, HIV/Hepatitis C Montefiore Medical Center sreynoso@montefiore.org
- Shellyann Vassell Nurse North Shore University Hosptial svassell@nshs.edu
- Shumenghui Zhai Research Associate III Temple University tue85115@temple.edu
- Steven Linick Pharmacy Rep Echo Pharmacy slinick@echospecialty.com
- Tatiana Vera Program Supervisor Montefiore Medical Center tvera@montefiore.org
- Tiara Martin Peer Navigator Family Services Network of NY TIARAMARTIN9177@GMAIL.COM
- Tino Fuentes Co-Director of SEP Programs Ann’s Corner of Harm Reduction ffuentes@sachr.org
- Umaima Khatun MPH Intern DOHMH – Viral Hepatitis ukhatun@health.nyc.gov
- Yin Tan Associate Director, Community Programs Temple University – Center for Asian Health ytan@temple.edu
Last Updated on July 24, 2023 by HepFree NYC
Tags: Harm Reduction Hepatitis C Substance Abuse